Administrative and Public LawBanking and Financial Markets LitigationCivil Fraud, Asset Tracing and RecoveryCommercial LitigationCompetition LawConstruction and Engineering DisputesContentious Trusts, Estates and Private Wealth DisputesGroup Action LitigationInsolvency LitigationInsurance and Reinsurance LitigationInternational ArbitrationInvestigations and White Collar CrimeProduct LiabilityProfessional Negligence LitigationToxic Tort and ESG
Founded in 2012, Signature Litigation has grown into one of London’s pre-eminent specialist dispute resolution practices. From the outset, we set out to do things differently: a conflict-free, disputes-only platform designed to give clients the undivided focus and strategic agility that complex, high-stakes matters demand.
FIND OUT MORE
Established in 2017, Signature Litigation's Gibraltar office was founded to address growing demand for specialist expertise in commercial litigation and private wealth disputes on the Rock.
FIND OUT MORE
Signature Litigation AARPI houses one of France’s most enviable product liability practices, with the team also handling commercial and corporate litigation, insurance and reinsurance, toxic tort and ESG, civil fraud and asset tracing, international arbitration, administrative and public law.
FIND OUT MORE
Frankfurt has emerged as one of Europe's foremost financial and commercial centres and, increasingly, as a bridge between European and Asian markets. With that growth comes an increasing demand for sophisticated dispute resolution. Signature Litigation established its Frankfurt office to meet this need, bringing our conflict-free, disputes-only platform to the German market.
FIND OUT MOREPartner Sylvie Gallage-Alwis discusses how Toxic tort is developing even more negatively in France for businesses who are today the target of multiple disputes related to exposure to a substance or risk, in Le Monde du Droit. Sylvie's article was published in Le Monde du Droit, 11 May 2020, and can be found here.
Contrary to popular belief, American Toxic Tort exists in France and is developing even more negatively for businesses than across the Atlantic.
Sylvie discusses how companies are today the target of multiple disputes related to exposure to a substance or risk. She also addresses how the use of a suspected toxic substance gives rise to often uncontrollable litigation or threats of litigation that companies can only take seriously, like the one currently used in anxiety related to the potential development of Covid-19.
Sylvie Gallage-Alwis is one of the founding partners of the Paris office of Signature Litigation and heads its product liability practice. She is specialised in all cutting-edge complex disputes linked to products, namely product liability, product safety, toxic tort, mass litigation/class action, regulatory compliance, and environment.
